About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Eurasian Hematology-Oncology Group
http://www.ehog.net/
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Videos
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Videos
8th Eurasian Hematology Oncology Summit
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Palliative & Supportive Care
COVID-19
Basic Science
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Lung
Business
7th Eurasian Hematology Oncology Summit
COVID-19
Leukemia
Lymphoma
Myeloma
MDS and MPN
Xth Eurasian Hematology-Oncology Congress
Breast
Lung
Hematologic Oncology
Gastrointestinal
Genitourinary
General Oncology
Sarcoma
Skin
Head & Neck
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
F
Is HSCT Necessary to Consolidate Hematological Remission After CAR-T in ALL?
By
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
FEATURING
Francesco Saglio
By
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
FEATURING
Francesco Saglio
0 views
February 16, 2024
Comments
0
Login to view comments.
Click here to Login
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
Featured Video
16:51
Incyte
Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk
Feat.
C. Harrison
Leukemia
17:15
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Clinical Case of BPDCN
Feat.
H. Hamed
19:51
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
A 50-Year Personal Perspective on the Treatment of AML
Feat.
C. Schiffer
12:11
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Induction Therapy Choices and Responses of ALL in a Third World Coun…
Feat.
A. Zafar
14:43
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Is HSCT Necessary to Consolidate Hematological Remission After CAR-T…
Feat.
F. Saglio
07:25
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
BK Virus Infections in Pediatric Leukemia During Treatment
Feat.
D. KaçAr
08:11
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Molecular Characteristics and Treatment Response to COG-ALL Protocol…
Feat.
B. GüNer Yılmaz
13:09
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Inaticabtagene Autoleucel Treatment in Adult R/R B-Cell ALL in China
Feat.
L. Lulu
16:52
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
CLL: Future Perspectives and Unanswered Questions
Feat.
A. Ferrajoli
15:36
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Debates in CLL: The Case for Combination Therapy in 1L
Feat.
A. Ibrahim
12:23
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Debates in CLL: The Case for BTKi Monotherapy in 1L
Feat.
G. Musuraca
06:14
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
CLL Case Presentation: 72 y/o Male With Cardiac Comorbidities
Feat.
F. Eda Nuhoğlu Kantarcı
08:11
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
State-of-the-Art in CLL Treatment
Feat.
A. Cuneo
08:54
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Future Perspectives in CML
Feat.
N. Chaudhri
07:46
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Debates in CML: Imatinib is NOT the Best Choice for 1L TKI
Feat.
T. Sacha
13:06
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Debates in CML: Imatinib is the Best Choice for 1L TKI
Feat.
G. Saglio
14:31
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
CML Case Presentation: A Patient With Multiple TKI Failure
Feat.
D. Özmen İbiş
12:22
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
CML Case Presentation: A Young Patient With TKI Intolerance and Resi…
Feat.
C. Fava
14:44
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
CML: State-of-the-Art and Progress Towards Cure
Feat.
P. Raanani
20:06
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Current and Future Approaches to the Treatment of B- and T-ALL
Feat.
D. Hoelzer
18:14
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Acute Promyelocytic Leukemia: Risk Stratification and New Treatment …
Feat.
S. ÇAkı Kılıç
16:07
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Pediatric AML: Diagnosis and Risk Stratification
Feat.
N. Karadaş
26:45
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Therapeutic Challenges and BMT in Pediatric Patients With CML
Feat.
T. Ileri
26:32
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Pediatric CML Treatment Options and Management
Feat.
O. TüFekçI GüRocak
08:29
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Effect of GVHD Prophylaxis on the Leukemia-Free Survival in Pediatri…
Feat.
O. Aylin Boran
15:56
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Pediatric CML Diagnosis
Feat.
A. Meral Güneş
08:34
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Adults With ALL: When Not to Transplant
Feat.
E. Jabbour
13:19
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Adults With ALL: When to Transplant
Feat.
S. Chiaretti
08:39
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Feasibilty of Therapy for Elderly Ph+ ALL Patients
Feat.
G. Marconi
15:43
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Recent Updates in ALL Treatment
Feat.
G. Martinelli
14:12
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Future Directions in AML: Optimizing Doublets and Triplets to Improv…
Feat.
N. Daver
05:14
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Case Discussion: Ven+Aza Maintanance After Intensive Induction in 33…
Feat.
M. Yilmaz
11:17
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
State of the Art: Role of Maintenance Therapy in AML
Feat.
Z. Aziz
